By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The heart’s rhythm is captured by a tiny, wearable device called a Holter monitor. It is used to identify or estimate the likelihood of cardiac arrhythmias. If a conventional electrocardiogram (ECG or EKG) doesn’t reveal enough information regarding the state of the heart, a Holter monitor test may be performed.
Your heart’s rhythm won’t significantly change according to a typical Holter monitor result. Even the majority of people occasionally experience benign arrhythmias that have no symptoms at all.
The Global holter monitoring systems market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
UltraLinQ to showcase revolutionary new end-to-end Holter monitoring system. The diagnosis of cardiac arrhythmias is revolutionised by a novel end-to-end patient monitoring approach introduced by UltraLinQ Healthcare Solutions.
The firm will be exhibiting a revolutionary UltraLinQ Holter Service at the ABHI UK Pavilion. This service is made possible by LifeSignals, a full-featured Wireless Holter Monitoring ECG Analysis and Reporting System that offers wireless ECG recording with clinical-grade wearable biosensors.
45% of all arrhythmias go unnoticed during a 24-hour Holter monitoring period utilised in standard clinical practise, according to studies. Increasing the monitoring duration to seven days can enhance detection of all arrhythmias to about 97%, lowering the risk of stroke.
With the help of the UltraLinQ Holter Service, hospitals and specialty clinics may offer extended Holter services to patients physically present at their facilities or remotely at home. The gadget is used to analyse the patient’s heart rhythm as they go about their regular daily activities.
It can record data for up to seven days and allows for the creation of high-quality Holter reports within 36 hours by qualified cardiac technicians. The method gives hospitals more freedom in how they deliver treatment to a larger patient population using a pay-per-use model without overtaxing medical staff.
The disposable, single-use wearable biosensor gadget enables wire-free, continuous patient monitoring. The patients may exercise, sleep, and take showers as usual while wearing it with little interference to their everyday routine. Additionally, the medical gadget is made to be simple to apply without causing pain or skin irritation.